We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guidance Eases Use of PERs in Basic Clinical Research
Guidance Eases Use of PERs in Basic Clinical Research
The Canadian government has released a draft guidance aimed at streamlining the approval process for basic clinical trials using positron-emitting radiopharmaceuticals, or PERs.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor